| abstract |
The invention relates to compounds of formula (I) or their stereoisomers, tautomers or pharmaceutically acceptable salts, where all variables are as defined in this specification. These compounds are selective ROCK inhibitors. The present invention also relates to pharmaceutical compositions containing these compounds, and methods for treating cardiovascular, smooth muscle, oncological, neuropathological, autoimmune, fibrotic and / or inflammatory diseases with their use. |